Molina Healthcare, Inc $MOH Shares Bought by Empowered Funds LLC

Empowered Funds LLC grew its stake in Molina Healthcare, Inc (NYSE:MOH) by 81.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,420 shares of the company’s stock after purchasing an additional 18,152 shares during the period. Empowered Funds LLC’s holdings in Molina Healthcare were worth $5,388,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Torren Management LLC purchased a new position in shares of Molina Healthcare during the 4th quarter valued at approximately $26,000. MUFG Securities EMEA plc purchased a new stake in Molina Healthcare during the second quarter worth $48,000. Cromwell Holdings LLC boosted its holdings in Molina Healthcare by 211.9% during the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after buying an additional 125 shares in the last quarter. Quarry LP purchased a new stake in Molina Healthcare during the fourth quarter worth $32,000. Finally, Triumph Capital Management grew its position in Molina Healthcare by 4,625.0% during the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after buying an additional 185 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Activity

In related news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by company insiders.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $196.10 on Friday. The company’s fifty day moving average price is $207.67 and its 200 day moving average price is $177.58. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $244.89. The stock has a market capitalization of $10.24 billion, a P/E ratio of -1,089.40, a P/E/G ratio of 28.02 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. The company had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The firm’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.48 EPS. As a group, equities research analysts anticipate that Molina Healthcare, Inc will post 5.29 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on MOH shares. Zacks Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 23rd. Sanford C. Bernstein set a $286.00 target price on shares of Molina Healthcare in a research note on Monday, July 13th. Wells Fargo & Company dropped their target price on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating on the stock in a research report on Tuesday, July 28th. Wall Street Zen upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, May 2nd. Finally, Morgan Stanley upped their price target on Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a report on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Molina Healthcare currently has an average rating of “Hold” and an average target price of $202.44.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.